Hi [[ session.user.profile.firstName ]]

Conquering Aging: Novel Technology Disruptions in the Anti-Aging Industry

The anti-aging industry is moving toward a “prevent-manage-repair” continuum that is creating novel market opportunities such as pharmacological targeting of aging, the “drug-as-a-service” business model, the use of digital pills to track drug consumption and adherence, and digital therapies that will help lower costs and reduce side effects.

Key Takeaways:
• Discover innovations in anti-aging drugs and therapies, novel nutrition, and digital tools
• Engage with thought leaders to understand the dynamics around significant market trends, innovative business models, and game-changing companies.
• Uncover key investment opportunities and growth potential.
Recorded Sep 18 2018 70 mins
Your place is confirmed,
we'll send you email reminders
Presented by
Frost & Sullivan's Global Transformational Health Experts, Insilico Medicine, ChromaDex, Dthera Sciences
Presentation preview: Conquering Aging: Novel Technology Disruptions in the Anti-Aging Industry

Network with like-minded attendees

  • [[ session.user.profile.displayName ]]
    Add a photo
    • [[ session.user.profile.displayName ]]
    • [[ session.user.profile.jobTitle ]]
    • [[ session.user.profile.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(session.user.profile) ]]
  • [[ card.displayName ]]
    • [[ card.displayName ]]
    • [[ card.jobTitle ]]
    • [[ card.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(card) ]]
  • Channel
  • Channel profile
  • Cybersecurity in Healthcare: 3 Ways Organizations Can Mitigate Security Risks Recorded: Jul 25 2019 50 mins
    Mike Jude, Ph.D., Research Manager, Frost & Sullivan, Erin Benson, Director, Market Planning, LexisNexis Risk Solutions
    What is complicating healthcare cybersecurity?

    Solution providers need to articulate their value proposition, not only in business terms, but also in terms of the impact their technology will have on the delivery of healthcare and, ultimately, the wellbeing of the patient.

    Key Takeaways:

    • Identify primary barriers to establishing excellent healthcare cybersecurity.
    • What impact will IoT and cloud services, including computing and storage, have on healthcare cybersecurity?
    • What are the substantial growth opportunities?
  • Digital Health Predictions and Trends—What to Expect in 2020 Recorded: Jun 11 2019 56 mins
    Mike Jude (Moderator), Frost & Sullivan Digital Health Experts
    Are you curious about how Digital Health will change through the end of 2020? Are you looking for new growth opportunities to capitalize on now to ensure a successful future?

    We invite you to attend the complimentary webinar, Digital Health Predictions and Trends—What to Expect in 2020, moderated by Mike Jude, Ph.D., Research Manager, along with our Digital Health experts. They will provide expert insight and predictions on new developments poised to help you build a growth pipeline. Insights will be based on the likely impact of technologies such as AI, Big Data, predictive analytics, and telemedicine, as well as evolving areas such as new billing practices and Femtech. Learn about real-world success stories as well as potential mistakes you must avoid.

    Key Takeaways:
    • Learn what the digital health market potential is through 2020
    • Better understand which technologies and services will be the primary industry drivers in the short term
    • Identify growth opportunities in digital health
    • Explore the impact of new technologies and regulations on market potential
    • Gain insight on new approaches to achieve more efficient management of the healthcare process
  • Growth Opportunities in the Healthcare Technology and Biosciences Sector Recorded: May 14 2019 60 mins
    Charlie Whelan, Vice President of Consulting, Transformational Health, Americas, Frost & Sullivan
    For most cities and states, the healthcare technology and biosciences sector is one of the most attractive industries of the future that can grow their communities. However, that attention attracts significant competition among players seeking to expand in a field that is highly complex. How should your community address this industry, and what is the best path to nurturing start-ups, retaining existing employers, attracting new companies and encouraging workforce development?

    Key Takeaways:

    • The healthcare technology and biosciences market is large and complex. Learn how the industry is structured and which segments might align best with your community.
    • Cities and states across the country are all competing to grow their own biosciences economies. Find out what types of programs and strategies are the most effective.
    • Come away with a simple model for assessing your own community’s strength relative to the healthcare technology and biosciences market.
  • Future of Clinical Laboratories—Winning Strategies & Growth Opportunities Recorded: Mar 5 2019 64 mins
    Divyaa Ravishankar, Industry Principal,Frost & Sullivan, Kyle Fetter, Executive Vice President, XIFIN
    What are the winning strategies for a laboratory to be successful? This webinar will focus on the state of the clinical laboratories market in the US, Canada, and Europe. Given the reimbursement cuts, it is essential to understand how this can impact the revenue-generating abilities of clinical laboratories and what strategies they can take now to keep the business profitable.

    Frost & Sullivan invites you to join Divyaa Ravishankar, Industry Principal, Frost & Sullivan and Kyle Fetter, Executive Vice President & General Manager of Diagnostic Services, XIFIN, for the webinar: Future of Clinical Laboratories—Winning Strategies & Emerging Growth Opportunities. The event will provide an overview of the current state of clinical laboratories and recommendations for future success followed by an interactive, live question-and-answer session.

    Key Takeaways:

    • Understand what is driving business for clinical laboratories and what will change in the future
    • Learn how are clinical laboratories adjusting to the declining reimbursement situation
    • Gain insight on ways a data-driven approach can help laboratories increase efficiency
    • Better understand how blockchain applies in the world of clinical laboratory services testing
  • 2019 Life Science Predictions: Decoding 5 Incredible Growth Opportunities Recorded: Feb 6 2019 74 mins
    Nitin Naik, Unmesh Lal, Khushbu Jain, Fred Mao, Barbara Gilmore, Frost & Sullivan
    The Life Science industry is in a state of flux. While recent years have seen the advent of multiple novel technologies—such as IVF, CRISPR-Cas9, virtual clinical trials, and liquid biopsy—the industry today stands at a crossroads with challenges in scaling up and commercializing such technologies. The industry has now come to terms with new, path-breaking life science technologies that are helping make precision healthcare a reality. Chinese investments into the US biopharma industry jumped to $4.5 billion in 2018. An exclusive fireside chat with our US and China analysts will uncover trends in cross-border investments and growth opportunities in these two markets.

    Key Takeaways:

    • Establish the leading factors that will influence the size and direction of the global life sciences market in 2019.
    • Build clarity on technology developments in the global life sciences market in 2018 that will have an impact during 2019.
    • Identify the business models used to commercialize and distribute novel life science solutions.
    • Discover the key growth opportunities and strategic imperatives for companies in 2019.
  • 2019 Healthcare Predictions – Growth Opportunities, Technology, and Trends Recorded: Nov 8 2018 72 mins
    Reenita Das, Partner and Senior Vice President, Kamaljit Behera, Industry Analyst, Transformational Healthcare
    In 2019, digital health will come of age. Favorable reimbursement policies for clinically relevant digital health applications will expand care delivery models beyond physical medicine. 2019 will be a reality check for two of the most hyped healthcare technologies of this decade—Artificial Intelligence (AI) and Blockchain.

    Globally, 2019 will be a year of value-based care as we expect the outcomes-based care focus to globalize. Access to affordable and quality care will be a key political agenda for upcoming elections in emerging markets such as Asia, Africa, and Central and Eastern European countries. Non-traditional players with digital technologies, such as Amazon, Ali Health, Microsoft and IBM, will provide the required impetus to public health systems to ensure accessibility and affordability of care.

    Key Takeaways:
    • Learn how many of our 2018 predictions came true
    • Gain insight into the critical issues affecting the healthcare industry globally
    • Identify new opportunities connected to the pharmaceutical, biotechnology, medical technologies, diagnostics, and healthcare IT sectors
  • Medical Marijuana Market Trends—Future Clinical Role of Medical Marijuana & CBD Recorded: Oct 30 2018 48 mins
    Nitin Naik (Moderator) Barbara Gilmore, Senior Consultant, Frost & Sullivan, Dr. Joseph C. Maroon, University of Pittsburgh
    Medical cannabis use is driving industry revenues into the billions. Investments by pharmaceutical and Big Tobacco companies in the development of cannabis and CBD-based products and devices, along with healthcare-conscious consumers having access to these products, are spurring growth. Physicians, aware of increasingly widespread medical marijuana legalization, are interested in understanding the potential of these treatments. In US states where cannabis is approved, the use of prescription drugs, including the use of opioids, has decreased.

    Key Takeaways:
    • Learn about a variety of medical marijuana science and clinical uses/applications (patient experiences)
    • Discover health-related applications of medical marijuana based on interactions with the endocannabinoid system
    • Explore the latest clinical research in cancer, neurological, psychological, metabolic and pain disorders using medical marijuana
  • New Commercialization and Revenue Strategies for Medical Technology Companies Recorded: Oct 9 2018 61 mins
    Charlie Whelan, Vice President of Consulting, Transformational Health, Frost & Sullivan
    In a market where products are increasingly commoditized and healthcare providers are being rewarded for outcomes, medical technology companies must realign their current and future business models to account for disruptive forces in the industry. Companies that have historically competed based on engineering skill and clinical evidence are finding new sources of innovation and value creation. Many medical device companies still struggle to unlock this value and find effective ways to partner with their healthcare customers. Firms that fail to capture this opportunity will fall further behind competitors who are creating revenue streams built on delivering outcomes supported by data-empowered services.
  • Conquering Aging: Novel Technology Disruptions in the Anti-Aging Industry Recorded: Sep 18 2018 70 mins
    Frost & Sullivan's Global Transformational Health Experts, Insilico Medicine, ChromaDex, Dthera Sciences
    The anti-aging industry is moving toward a “prevent-manage-repair” continuum that is creating novel market opportunities such as pharmacological targeting of aging, the “drug-as-a-service” business model, the use of digital pills to track drug consumption and adherence, and digital therapies that will help lower costs and reduce side effects.

    Key Takeaways:
    • Discover innovations in anti-aging drugs and therapies, novel nutrition, and digital tools
    • Engage with thought leaders to understand the dynamics around significant market trends, innovative business models, and game-changing companies.
    • Uncover key investment opportunities and growth potential.
  • How MedTech Will Accelerate the Smart Home Billion-Dollar Market & Revamp Care Recorded: Aug 30 2018 59 mins
    Sowmya Rajagopalan, Global Program Director, Siddharth Shah, Industry Analyst, Transformational Health, Frost & Sullivan
    Healthcare delivery is moving away from traditional healthcare centers such as hospitals and clinics. Other non-traditional areas are becoming centers for healthcare delivery to provide more urgent, convenient and cost-effective care. This path ends at home—where a patient spends the most time, is most comfortable and can recover best. This area provides opportunities for much more than just care delivery. Homes, if enabled with the right care equipment, devices, and technology, can serve not only patient screening, monitoring, and disease management, but also health and wellness monitoring opportunities. Several companies have already recognized this trend and, along with startups, are targeting it to capitalize early.
  • The Impact of Artificial Intelligence in Medical Imaging Recorded: Aug 9 2018 56 mins
    Nadim Daher,Industry Principal, Siddharth Shah, Industry Analyst, Frost & Sullivan's Global Transformational Health
    Medical imaging has become a leader for the application of artificial intelligence technologies in the healthcare space, especially recently with deep learning techniques. This is evident from the fact that over 90 companies have set out to develop and commercialize AI-based solutions for the medical imaging industry. The number continues to grow as new start-ups emerge, as incumbents develop native AI solutions, and as tech companies move into the field, creating a highly dynamic ecosystem. With various countries edging past the innovator adoption phase and into the early adopter one, the time is now for stakeholders to refine and test their value proposition, partnership approach, and go-to-market strategies.

    Key Takeaways:
    • How far we have reached over the past five years and the current lay of the land
    • Where we are headed over the next five years and the direction of industry progress
    • Deep-dive into the opportunity for automation, acceleration and augmentation of medical image analysis
    • Anticipate the advent of intelligent medical imaging machines with embedded AI
  • Digital Therapeutics: Trends and Growth Opportunities Recorded: Jun 26 2018 61 mins
    Frost & Sullivan's Global Digital Health Team, Wolf Shlagman CEO - Care Angel, Amer Haider CEO - Doctella
    Digital therapeutics presents a significant opportunity for traditional pharmaceutical therapeutics and information technology (IT) capabilities to influence a new approach to increase positive patient outcomes while reducing the overall cost of healthcare.

    Key Takeaways:
    · Gain expert insight into the accurate definition of digital therapeutics and market participants.
    · Learn about new solutions from mHealth companies that will combine apps, patient education, professional intervention and peer support to increase patient engagement and medication adherence by augmenting or replacing traditional drug therapeutics.
    · Hear opportunities to utilize digital therapeutics to improve medical workflow and patient communications.
    · Learn about some of the critical milestones related to digital therapeutics.
  • The Rise of Digital Enterprise: Growth Strategies for Healthcare Companies Recorded: May 31 2018 59 mins
    Nitin Naik, Slava Akmaev Chief Analytics Officer, BERG, Guillaume Kerboul, Dassault Systemes; Dr. Thorsten Harzer, QIAGEN
    Digital Transformation is powering growth opportunities in Smart R&D, Patient Engagement, and Healthcare eCommerce. The explosion of patient centricity and technological advancement in big data analytics, cloud and artificial intelligence are putting severe pressures on companies to leverage all types of data (clinical, social media, IOT, etc.) in innovative ways. While the industry is decidedly upbeat on this new trajectory, there are heightened concerns about managing data privacy, especially for data flows outside the traditional ecosystem.

    Key Takeaways:
    • Learn about trends and growth opportunities in the Life sciences IT sector
    • Discuss hot topics, including Smart R&D, Digital Manufacturing, Connected patient and IVD eCommerce (B2C models)
    • Hear from industry leaders about company growth strategies and best practices for implementing digital solutions
    • Gain perspectives on M&A’s and the impact of investments from Big Tech companies
  • 2018 Frost & Sullivan Predictions and Outlook for Digital Health Recorded: Feb 22 2018 51 mins
    Daniel Ruppar, Global Program Director, Analysts from Frost & Sullivan's Global Digital Health Team
    Expert Insights You Will Not Want to Miss:

    • Hear market predictions from world-renowned analysts
    • Learn areas of growth and controversy for 2018 in digital health and health IT
    • Discussions on hot areas including AI, Digital Therapeutics and Blockchain
    • Movements of major ICT and Technology companies in their Healthcare strategy
    • Understand the critical vendors to watch for this year
  • The Picture Perfect Future of the US Medical Imaging Industry Recorded: Jan 23 2018 62 mins
    Frost & Sullivan Transformational Health Team, Shannon Werb, vRad
    The US medical imaging industry is transforming to cope with the challenges of the present and the demands of the future. The current care provision landscape is highly fragmented, and a coherent strategy is required to enhance interoperability among stakeholders across the imaging ecosystem. Stakeholders across the industry must also come together to eliminate redundancies and duplications, and streamline the imaging process, to improve the patient experience.
  • Digital Health Markets Update: From AI to Zzzs - What Comes Next? Recorded: Aug 29 2017 53 mins
    Daniel Ruppar, Global Program Director - Digital Health
    Digital health brings a diverse range of growth opportunities for vendors across the value chain. As the space evolves we have experienced a multitude of stepwise successes and stellar failures, yet funding continues to flood the sector. Major moves continue to come into the industry from the broader vendor environment, underlining the importance of health in everyone’s lives and progressively in strategic interests of the C-Suite across the ecosystem. Join Frost & Sullivan in this webinar update showcasing different facets of the market, and learn why there’s something for everyone in digital health.
  • NGS: New Business Models in Diagnostics and Drug Development Recorded: Aug 9 2017 58 mins
    Frost & Sullivan Transformational Health Team, Dr. Misha Kapushesky,Genestack CEO and Dr. Elia Stupka,Boehringer Ingelheim
    Next-generation sequencing (NGS) has emerged as a key technology to deliver the next level of healthcare solutions. While the $1,000 genome was achieved in 2015, Frost & Sullivan predicts the $100 genome to be possible by 2024. The significant dip in cost of extracting genetic data has led to the creation of massive genomic data volumes that are expected to be some of the largest data sets globally by 2025, exceeding data generated by YouTube and Twitter.
  • Beyond Superior Care Quality—How Can APAC Hospitals Become Truly Patient Centric Recorded: Jul 26 2017 61 mins
    Frost & Sullivan, Gabe Rjipma,Microsoft, Dr. Timothy Low, Farrer Park Hospital, David Vu, GE Healthcare Asia-Pacific
    Hospital information technology (Hospital IT) spending in Asia-Pacific (APAC) will grow at a compound annual growth rate of 9.7% between 2016 and 2021 to reach an estimated end-stage market size of more than $15 billion. Key growth opportunities in the region include solutions for Healthcare Data Continuity, Patient Engagement & Experience, Healthcare Cloud, Big Data & Analytics, and Healthcare Cybersecurity. However, the identification of these growth opportunities is only the first step toward succeeding as an ICT vendor in this market. The real demystification lies in understanding very specific target customer needs and then building a value proposition and business model that addresses those needs.
  • 2017 Frost & Sullivan Predictions in Diagnostics Recorded: Mar 23 2017 64 mins
    Transformational Health Team, Harry Glorikian, Board Advisor and Eunice Teo, Director, Business Development, QuantuMDx
    The global clinical diagnostics industry is undergoing a transformation propelled by laboratory consolidation and automation, an enormous move toward data-driven healthcare, large investments in unifying technologies, and renewed business models driven by products and value-added services. There is immense pressure on companies to radically improve new product innovation, manufacturing, and distribution of technologies such as point-of-care molecular diagnostics to capture new growth opportunities in the precision medicine market.
  • 2017 Frost & Sullivan Predictions in Digital Health Recorded: Jan 31 2017 59 mins
    Digital Health Team: Daniel Ruppar, Nancy Fabozzi and Victor Camlek
    Over the past decade, the adoption of digital solutions has increased significantly throughout the healthcare industry. This exceptionally strong growth trajectory is expected to continue into the foreseeable future as U.S. healthcare organizations transform to meet the demand for more efficient, clinically integrated and decentralized care systems that serve empowered, technologically-savvy consumers who strongly value convenience and personalization.
Frost & Sullivan GIL Webcast Series
Our Healthcare webcasts cover Connected Health, Life Sciences and Advanced Medical Technologies to help you to better understand buyer-seller dynamics as the healthcare system transitions to digital information, the pace at which new and innovative medical devices and systems are being adopted and getting embedded into the typical clinical pathway, both in mature and emerging markets, and enables you to bring clarity to pharmaceutical/biotechnology, in-vitro diagnostics and life science research tools market decisions and implementation tactics.

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Conquering Aging: Novel Technology Disruptions in the Anti-Aging Industry
  • Live at: Sep 18 2018 3:00 pm
  • Presented by: Frost & Sullivan's Global Transformational Health Experts, Insilico Medicine, ChromaDex, Dthera Sciences
  • From:
Your email has been sent.
or close